Strategic Analysis of the 2026 Bioreactor Market: Process Intensification, Single-Use Technologies, and Digital Twins
As of early 2026, the global life sciences sector is characterized by a "bioprocessing revolution." The Bioreactor Market has evolved into the central engine for the mass production of monoclonal antibodies (mAbs), vaccines, and advanced therapy medicinal products (ATMPs). The industry has transitioned from rigid, stainless-steel paradigms toward flexible, modular, and highly automated...
0 Comentários 0 Compartilhamentos 16 Visualizações 0 Anterior